NPPA sets retail prices for 15 drug formulations

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) said on Tuesday it had capped the retail prices of 15 formulations used to treat various diseases, including diabetes.

The drug price regulator said the prices were set after a meeting held in the last week of March.

Companies producing these drugs will now have to follow the new retail prices recommended by the price regulator.

“The NPPA has set retail prices for 15 formulations under the Medicines (Price Control) Order 2013 based on the decision of the 96th meeting of the Authority dated 24 March,” the regulator said in its order.

The price of Metformin (extended release) + Teneligliptin tablet, manufactured and marketed by Associated Biotech, Dales Laboratories, has been set at Rs 7.14 per tablet.

Similarly, the retail price of Dapagliflozin + Metformin Hydrochloride extended release tablet has been set at Rs 10.7 per tablet.

These two tablets are used to treat diabetes.

The NPPA has also set the retail price of human normal immunoglobulin for intravenous use, intended for the treatment of certain diseases caused by lack of antibodies in the blood, at Rs 177.85 for a 10ml vial.

Also, the retail price of a single sustained-release tablet of medroxyprogesterone acetate, a hormone that helps regulate ovulation, has been set at Rs 14.04.

The NPPA said manufacturers must issue a price list to the regulator through the Integrated Drug Database Management System (IPDMS) and submit a copy to the comptroller and drug dealers in the country. ‘State.

Under the Medicines (Price Controls) Order 2013, every retailer and reseller must display a price list provided by the manufacturer, where they operate, in such a way that it is easily accessible to anyone wishing to view it, he added.

The NPPA has the mandate to set/revise the prices of controlled bulk drugs and formulations and to enforce the prices and availability of drugs in the country. It also monitors the prices of deregulated drugs in order to keep them at reasonable levels.

The regulatory body implements and enforces the provisions of the Medicines (Price Control) Ordinance. It is also responsible for recovering from consumers amounts overcharged by manufacturers for controlled drugs.

About Margie Peters

Check Also

The coolest back-to-school gear for elementary school kids

As they have done for decades, elementary schools are currently sending parents a list of …